Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 195

1.

Novel and conventional biomarkers for prediction of incident cardiovascular events in the community.

Melander O, Newton-Cheh C, Almgren P, Hedblad B, Berglund G, Engström G, Persson M, Smith JG, Magnusson M, Christensson A, Struck J, Morgenthaler NG, Bergmann A, Pencina MJ, Wang TJ.

JAMA. 2009 Jul 1;302(1):49-57. doi: 10.1001/jama.2009.943.

PMID:
19567439
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Assessment of conventional cardiovascular risk factors and multiple biomarkers for the prediction of incident heart failure and atrial fibrillation.

Smith JG, Newton-Cheh C, Almgren P, Struck J, Morgenthaler NG, Bergmann A, Platonov PG, Hedblad B, Engström G, Wang TJ, Melander O.

J Am Coll Cardiol. 2010 Nov 16;56(21):1712-9. doi: 10.1016/j.jacc.2010.05.049.

PMID:
21070922
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults.

Kistorp C, Raymond I, Pedersen F, Gustafsson F, Faber J, Hildebrandt P.

JAMA. 2005 Apr 6;293(13):1609-16.

PMID:
15811980
[PubMed - indexed for MEDLINE]
4.

Pro-A-type natriuretic peptide, proadrenomedullin, and N-terminal pro-B-type natriuretic peptide used in a multimarker strategy in primary health care in risk assessment of patients with symptoms of heart failure.

Alehagen U, Dahlström U, Rehfeld JF, Goetze JP.

J Card Fail. 2013 Jan;19(1):31-9. doi: 10.1016/j.cardfail.2012.11.002.

PMID:
23273592
[PubMed - indexed for MEDLINE]
5.

Prognostic value of multiple emerging biomarkers in cardiovascular risk prediction in patients with stable cardiovascular disease.

Ahluwalia N, Blacher J, Szabo de Edelenyi F, Faure P, Julia C, Hercberg S, Galan P.

Atherosclerosis. 2013 Jun;228(2):478-84. doi: 10.1016/j.atherosclerosis.2013.03.017. Epub 2013 Mar 26.

PMID:
23582589
[PubMed - indexed for MEDLINE]
6.

Biomarkers to predict recurrent cardiovascular disease: the Heart and Soul Study.

Shlipak MG, Ix JH, Bibbins-Domingo K, Lin F, Whooley MA.

Am J Med. 2008 Jan;121(1):50-7. doi: 10.1016/j.amjmed.2007.06.030.

PMID:
18187073
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Prognostic value of NT-pro-BNP and hs-CRP for risk stratification in primary care: results from the population-based DETECT study.

Leistner DM, Klotsche J, Pieper L, Palm S, Stalla GK, Lehnert H, Silber S, März W, Wittchen HU, Zeiher AM.

Clin Res Cardiol. 2013 Apr;102(4):259-68. doi: 10.1007/s00392-012-0530-5. Epub 2013 Jan 4.

PMID:
23288467
[PubMed - indexed for MEDLINE]
8.

Midregional proadrenomedullin for prediction of cardiovascular events in coronary artery disease: results from the AtheroGene study.

Wild PS, Schnabel RB, Lubos E, Zeller T, Sinning CR, Keller T, Tzikas S, Lackner KJ, Peetz D, Rupprecht HJ, Bickel C, Morgenthaler NG, Papassotiriou J, Tiret L, Münzel T, Blankenberg S.

Clin Chem. 2012 Jan;58(1):226-36. doi: 10.1373/clinchem.2010.157842. Epub 2011 Nov 7.

PMID:
22065157
[PubMed - indexed for MEDLINE]
Free Article
9.

Use of multiple biomarkers to improve the prediction of death from cardiovascular causes.

Zethelius B, Berglund L, Sundström J, Ingelsson E, Basu S, Larsson A, Venge P, Arnlöv J.

N Engl J Med. 2008 May 15;358(20):2107-16. doi: 10.1056/NEJMoa0707064.

PMID:
18480203
[PubMed - indexed for MEDLINE]
Free Article
10.

Comparison of midregional pro-A-type natriuretic peptide and the N-terminal pro-B-type natriuretic peptide for predicting mortality and cardiovascular events.

van Hateren KJ, Alkhalaf A, Kleefstra N, Groenier KH, de Jong PE, de Zeeuw D, Gans RO, Struck J, Bilo HJ, Gansevoort RT, Bakker SJ.

Clin Chem. 2012 Jan;58(1):293-7. doi: 10.1373/clinchem.2011.166348. Epub 2011 Sep 26.

PMID:
21948291
[PubMed - indexed for MEDLINE]
Free Article
11.

MR-proANP and MR-proADM for risk stratification of patients with acute chest pain.

Tzikas S, Keller T, Ojeda FM, Zeller T, Wild PS, Lubos E, Kunde J, Baldus S, Bickel C, Lackner KJ, Münzel TF, Blankenberg S.

Heart. 2013 Mar;99(6):388-95. doi: 10.1136/heartjnl-2012-302956. Epub 2012 Dec 4.

PMID:
23213173
[PubMed - indexed for MEDLINE]
12.

Prognostic utility of novel biomarkers of cardiovascular stress: the Framingham Heart Study.

Wang TJ, Wollert KC, Larson MG, Coglianese E, McCabe EL, Cheng S, Ho JE, Fradley MG, Ghorbani A, Xanthakis V, Kempf T, Benjamin EJ, Levy D, Vasan RS, Januzzi JL.

Circulation. 2012 Sep 25;126(13):1596-604. Epub 2012 Aug 20.

PMID:
22907935
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individuals.

Yeboah J, McClelland RL, Polonsky TS, Burke GL, Sibley CT, O'Leary D, Carr JJ, Goff DC, Greenland P, Herrington DM.

JAMA. 2012 Aug 22;308(8):788-95. doi: 10.1001/jama.2012.9624.

PMID:
22910756
[PubMed - indexed for MEDLINE]
14.

Comparative value of coronary artery calcium and multiple blood biomarkers for prognostication of cardiovascular events.

Rana JS, Gransar H, Wong ND, Shaw L, Pencina M, Nasir K, Rozanski A, Hayes SW, Thomson LE, Friedman JD, Min JK, Berman DS.

Am J Cardiol. 2012 May 15;109(10):1449-53. doi: 10.1016/j.amjcard.2012.01.358. Epub 2012 Mar 16.

PMID:
22425333
[PubMed - indexed for MEDLINE]
15.

Significance of a multiple biomarkers strategy including endothelial dysfunction to improve risk stratification for cardiovascular events in patients at high risk for coronary heart disease.

Nozaki T, Sugiyama S, Koga H, Sugamura K, Ohba K, Matsuzawa Y, Sumida H, Matsui K, Jinnouchi H, Ogawa H.

J Am Coll Cardiol. 2009 Aug 11;54(7):601-8. doi: 10.1016/j.jacc.2009.05.022.

PMID:
19660689
[PubMed - indexed for MEDLINE]
Free Article
16.

Multiple endothelial biomarkers and noninvasive vascular function in the general population: the Gutenberg Health Study.

Schnabel RB, Wild PS, Schulz A, Zeller T, Sinning CR, Wilde S, Kunde J, Lubos E, Lackner KJ, Warnholtz A, Gori T, Blankenberg S, Munzel T; Gutenberg Health Study Investigators.

Hypertension. 2012 Aug;60(2):288-95. doi: 10.1161/HYPERTENSIONAHA.112.191874. Epub 2012 Jun 11.

PMID:
22689741
[PubMed - indexed for MEDLINE]
Free Article
17.

N-terminal pro-B-type natriuretic peptide and the prediction of primary cardiovascular events: results from 15-year follow-up of WOSCOPS.

Welsh P, Doolin O, Willeit P, Packard C, Macfarlane P, Cobbe S, Gudnason V, Di Angelantonio E, Ford I, Sattar N.

Eur Heart J. 2013 Feb;34(6):443-50. doi: 10.1093/eurheartj/ehs239. Epub 2012 Aug 31. Erratum in: Eur Heart J. 2013 Apr;34(15):1094.

PMID:
22942340
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Multiple marker approach to risk stratification in patients with stable coronary artery disease.

Schnabel RB, Schulz A, Messow CM, Lubos E, Wild PS, Zeller T, Sinning CR, Rupprecht HJ, Bickel C, Peetz D, Cambien F, Kempf T, Wollert KC, Benjamin EJ, Lackner KJ, Münzel TF, Tiret L, Vasan RS, Blankenberg S.

Eur Heart J. 2010 Dec;31(24):3024-31. doi: 10.1093/eurheartj/ehq322. Epub 2010 Sep 18.

PMID:
20852293
[PubMed - indexed for MEDLINE]
Free Article
19.

Plasma natriuretic peptide levels and the risk of cardiovascular events and death.

Wang TJ, Larson MG, Levy D, Benjamin EJ, Leip EP, Omland T, Wolf PA, Vasan RS.

N Engl J Med. 2004 Feb 12;350(7):655-63.

PMID:
14960742
[PubMed - indexed for MEDLINE]
Free Article
20.

Evaluation of multiple biomarkers of cardiovascular stress for risk prediction and guiding medical therapy in patients with stable coronary disease.

Sabatine MS, Morrow DA, de Lemos JA, Omland T, Sloan S, Jarolim P, Solomon SD, Pfeffer MA, Braunwald E.

Circulation. 2012 Jan 17;125(2):233-40. doi: 10.1161/CIRCULATIONAHA.111.063842. Epub 2011 Dec 16.

PMID:
22179538
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk